Andrew James Kelley
Profile
Andrew James Kelley worked as Vice President of European Operations at Cardinal Health, Inc. He then worked as Vice President of UK & France Operations at Patheon, Inc. He later became the Chief Operating Officer at NextPharma Technologies Ltd.
Prior to that, he worked as an Engineer of Process & Technical Services at Esso Chemicals Ltd.
He also served as the Chief Operating Officer at NextPharma Technologies Holding Ltd.
Mr. Kelley earned an undergraduate degree from the University of Birmingham and an MBA from Henley Management College.
Former positions of Andrew James Kelley
| Companies | Position | End |
|---|---|---|
NextPharma Technologies Holding Ltd.
 NextPharma Technologies Holding Ltd. Pharmaceuticals: MajorHealth Technology NextPharma Technologies Holding Ltd. operates as a pharmaceutical contract development and manufacturing firm. It specializes in modified release technologies and in product manufacturing including hormones, penicillin, and cephalosporin. The company was founded on January 2, 2003 and is headquartered in London, the United Kingdom. | Chief Operating Officer | 29/02/2016 |
NextPharma Technologies Ltd.
 NextPharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology NextPharma Technologies, In. develops, manufactures, packages, and distributes pharmaceutical products and formulations. The firm focuses on lyophilization, sterile fill finish and pellet technologies, and in product manufacturing including cyotoxics, hormones, penicillins, cephalosporins, and controlled drugs. The company was established on October 27, 2000 and is headquartered in London, the United Kingdom. | Chief Operating Officer | - |
| Esso Chemicals Ltd. | Corporate Officer/Principal | - |
| CARDINAL HEALTH, INC. | Chief Operating Officer | 16/08/2009 |
| PATHEON, INC. | Corporate Officer/Principal | - |
Training of Andrew James Kelley
| University of Birmingham | Undergraduate Degree |
| Henley Management College | Masters Business Admin |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| CARDINAL HEALTH, INC. | Distribution Services |
| Private companies | 4 |
|---|---|
Patheon, Inc.
 Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |
| Esso Chemicals Ltd. | |
NextPharma Technologies Ltd.
NextPharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology NextPharma Technologies, In. develops, manufactures, packages, and distributes pharmaceutical products and formulations. The firm focuses on lyophilization, sterile fill finish and pellet technologies, and in product manufacturing including cyotoxics, hormones, penicillins, cephalosporins, and controlled drugs. The company was established on October 27, 2000 and is headquartered in London, the United Kingdom. | Health Technology |
NextPharma Technologies Holding Ltd.
NextPharma Technologies Holding Ltd. Pharmaceuticals: MajorHealth Technology NextPharma Technologies Holding Ltd. operates as a pharmaceutical contract development and manufacturing firm. It specializes in modified release technologies and in product manufacturing including hormones, penicillin, and cephalosporin. The company was founded on January 2, 2003 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Andrew James Kelley
